SELLAS Life Sciences (SLS) Cash from Investing Activities (2010 - 2023)
SELLAS Life Sciences (SLS) reported Cash from Investing Activities of -$3.0 million for Q3 2023, down 124.68% on a QoQ basis from $12.2 million in Q4 2017.
SELLAS Life Sciences (SLS) has 8 years of Cash from Investing Activities data on file, last reported at -$3.0 million in Q3 2023.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$3.0 million in Q3 2023, while the trailing twelve-month figure through Dec 2024 was -$3.0 million (changed 0.0% YoY) and the FY2023 annual result came in at -$5.5 million, down 22.22% from the prior year.
- Cash from Investing Activities eased to -$3.0 million in Q3 2023 per SLS's latest filing, from $12.2 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$3.0 million in Q3 2023 and bottomed at -$3.0 million in Q3 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -2.89 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 638.50 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -431.90 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -428.90 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -25.54 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | -3.00 Mn |
| Sep 30, 2023 | -3.00 Mn |
| Dec 31, 2017 | 12.16 Mn |
| Dec 31, 2017 | 12.16 Mn |
| Sep 30, 2017 | 25,000.00 |
| Sep 30, 2017 | 25,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Jun 30, 2017 | -7,000.00 |
| Mar 31, 2017 | -18,000.00 |
| Mar 31, 2017 | -18,000.00 |
| Dec 31, 2016 | 971,000.00 |
| Dec 31, 2016 | 971,000.00 |
| Sep 30, 2016 | -1.05 Mn |
| Sep 30, 2016 | -1.05 Mn |
| Mar 31, 2016 | -6,000.00 |
| Mar 31, 2016 | -6,000.00 |
| Dec 31, 2015 | 462,000.00 |
| Dec 31, 2015 | 462,000.00 |
| Sep 30, 2015 | -248,000.00 |
| Sep 30, 2015 | -248,000.00 |
| Jun 30, 2015 | -550,000.00 |
| Jun 30, 2015 | -550,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Mar 31, 2015 | -18,000.00 |
| Dec 31, 2014 | -109,000.00 |
| Dec 31, 2014 | -109,000.00 |
| Sep 30, 2014 | -3.08 Mn |
| Sep 30, 2014 | -3.08 Mn |
| Jun 30, 2014 | -312,000.00 |
| Jun 30, 2014 | -312,000.00 |
| Mar 31, 2014 | -2.03 Mn |
| Mar 31, 2014 | -2.03 Mn |
| Dec 31, 2013 | 12.73 Mn |
| Dec 31, 2013 | 12.73 Mn |
| Sep 30, 2013 | 720,000.00 |
| Sep 30, 2013 | 720,000.00 |
| Jun 30, 2013 | 131,000.00 |
| Jun 30, 2013 | 131,000.00 |
| Mar 31, 2013 | -10.09 Mn |
| Mar 31, 2013 | -10.09 Mn |
| Dec 31, 2011 | -101,000.00 |
| Dec 31, 2011 | -101,000.00 |
| Jun 30, 2011 | 155,000.00 |
| Jun 30, 2011 | 155,000.00 |
| Mar 31, 2011 | -40,000.00 |
| Mar 31, 2011 | -40,000.00 |
| Dec 31, 2010 | 5.95 Mn |
| Dec 31, 2010 | 5.95 Mn |
| Sep 30, 2010 | -5,000.00 |
| Sep 30, 2010 | -5,000.00 |